Literature DB >> 3116849

Correction of hypoprothrombinemia by immunosuppressive treatment of the lupus anticoagulant-hypoprothrombinemia syndrome.

D L Simel1, E W St Clair, J Adams, C S Greenberg.   

Abstract

A 66-year-old man with the lupus anticoagulant-hypoprothrombinemia syndrome was treated with cyclophosphamide and prednisone to correct a factor II deficiency prior to elective major surgery. Whereas the lupus anticoagulant activity persisted, functional factor II levels normalized and he underwent surgery without a bleeding diathesis. Immunosuppressive therapy may temporarily normalize factor II levels in patients with the lupus anticoagulant-hypoprothrombinemia syndrome and reduce the risk of excessive hemorrhage. The disparate response of the lupus anticoagulant and hypoprothrombinemia to immunosuppression suggests that the lupus anticoagulant did not directly cause the hypoprothrombinemia.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3116849     DOI: 10.1016/0002-9343(87)90772-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  9 in total

Review 1.  Treatment of the antiphospholipid syndrome.

Authors:  J C Piette; M Karmochkine; T Papo; L T Du; C Francès; B Wechsler
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

2.  Immunosuppressive treatment in a heart transplantation candidate with antiphospholipid syndrome.

Authors:  V Pengo; A Biasiolo; P Marson; G De Silvestro; C Agostini; U Livi
Journal:  Clin Rheumatol       Date:  1996-09       Impact factor: 2.980

3.  Pulmonary hemorrhage in pediatric lupus anticoagulant hypoprothrombinemia syndrome.

Authors:  Ji Soo Kim; Min Jae Kim; E Young Bae; Dae Chul Jeong
Journal:  Korean J Pediatr       Date:  2014-04-30

4.  Clinical importance of persistence of anticardiolipin antibodies in systemic lupus erythematosus.

Authors:  Y Ishii; K Nagasawa; T Mayumi; Y Niho
Journal:  Ann Rheum Dis       Date:  1990-06       Impact factor: 19.103

Review 5.  The 'antiphospholipid syndrome' and the 'lupus anticoagulant'.

Authors:  J S Cameron; G Frampton
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

Review 6.  The challenge of bleeding in antiphospholipid antibody-positive patients.

Authors:  Giulia Pazzola; Stéphane Zuily; Doruk Erkan
Journal:  Curr Rheumatol Rep       Date:  2015-02       Impact factor: 4.592

7.  Lupus anticoagulant-hypoprothrombinemia in healthy adult.

Authors:  Choon Hae Chung; Chi Young Park
Journal:  Korean J Intern Med       Date:  2008-09       Impact factor: 2.884

8.  Steady improvement of prothrombin levels after cyclophosphamide therapy in pediatric lupus anticoagulant hypoprothrombinemia syndrome (LAHPS).

Authors:  Andrea Taddio; AnneMarie C Brescia; Loredana Lepore; Carlos D Rose'
Journal:  Clin Rheumatol       Date:  2007-05-22       Impact factor: 2.980

Review 9.  Perioperative management of antiphospholipid antibody-positive patients.

Authors:  Katherine H Saunders; Doruk Erkan; Michael D Lockshin
Journal:  Curr Rheumatol Rep       Date:  2014-07       Impact factor: 4.592

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.